Prolacta Bioscience Appoints Dr. Sandra Sullivan As Director of Clinical Education and Professional Development

Oct 16, 2024•10 months ago

Position

Director

Company

Prolacta Bioscience

Sandra Sullivan

City Of IndustryBiotechnologyHealth Care

Description

Dr. Sandra Sullivan, recognized as a Human Milk Research Pioneer and among the first clinicians to study Prolacta's human milk-based fortifiers in the NICU, has been appointed as the director of clinical education and professional development at Prolacta Bioscience. She brings over 20 years of experience as a board-certified neonatologist and will be educating healthcare providers to enhance patient nutrition outcomes.

Company Information

Company

Prolacta Bioscience

Location

City Of Industry, California, United States

About

Prolacta Bioscience® is a global life sciences company dedicated to Advancing the Science of Human Milk® to improve health outcomes for critically ill and premature infants. More than 100,000 extremely premature infants worldwide2 have benefited from Prolacta's human milk-based products, which have been evaluated in more than 30 peer-reviewed clinical studies. Operating the world's first pharmaceutical-grade human milk processing facilities, Prolacta maintains the industry's strictest quality and safety standards, with over 20 validated tests for screening and testing human milk. Prolacta's manufacturing process uses vat pasteurization to ensure pathogen inactivation while protecting nutritional composition and bioactivity.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months